Stability of vancomycin in SyrSpend SF.

Volume: 16, Issue: 2, Pages: 167 - 9
Published: Oct 12, 2012
Abstract
Vancomycin is administered orally for the treatment of pseudomembranous colitis induced by Clostridium difficile. Vancomycin is marketed for this purpose by ViroPharma as VANCOCIN in 125-mg and 250-mg capsules. The need for other dose form options for those patients who cannot take capsules has led compounding pharmacies to seek other alternatives, namely oral solutions and suspensions. Additionally, some patients are unable to use suspending...
Paper Details
Title
Stability of vancomycin in SyrSpend SF.
Published Date
Oct 12, 2012
Journal
Volume
16
Issue
2
Pages
167 - 9
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.